Learning scenario two
LEARNING SCENARIO TWO
Raminder is determined to give up smoking, but finds it really difficult to break the habit. She smokes socially when out with friends, and no more than 6 to 8 a day. She enjoys the social aspect of smoking and is worried that she will have to miss nights out with her friends in order to avoid cravings. What product and advice from the below is most appropriate?
Click on the option you think is most appropriate from the choices below.
NICORETTE 15MG INVISIPATCH
A patch is helpful to control cravings and this strength is appropriate but she may still miss the habit of the smoking action when with friends.
Try Again
NICORETTE 4MG GUM
This strength of the gum is for those that smoke over 20 cigarettes a day.
Try Again
NICORETTE 25MG PATCH AND NICORETTE 2MG LOZENGE
This patch strength is for those that smoke 10 or more a day.
Try Again
NICORETTE QUICKMIST
Yes, the QuickMist is suitable for light and heavy smokers. You can advise her that Nicorette QuickMist can be used whenever she feels the urge to smoke, as well as to prevent cravings in social situations where these are likely to occur.
Thank you for completing this training module.
Continue to the assessment to test your knowledge and then log your learning.
1. ASH Smoking Statistics May 2021. https://ash.org.uk/uploads/Smoking-Statistics-Fact-Sheet.pdf?v=1697728811
2. NICE. NICE Guideline (NG209). Tobacco: preventing uptake, promoting quitting and treating dependence. Updated January 2023.
Available at: https://www.nice.org.uk/guidance/ng209
3. Taylor GMJ et al. Cochrane Database Syst Rev 2021;3(3):CD013522
4. Prochaska JJ and Benowitz NL. Sci Adv 2019:5(10): eaay9763
5. Royal College of Physicians of London (2016). Nicotine without smoke. Tobacco Harm Reduction: a report of the Tobacco Advisory Group of the Royal College of Physicians. Available at: https://www.rcp.ac.uk/media/xcfal4ed/nicotine-without-smoke_0.pdf
6. West R. NCSCT Briefing #8. Stop smoking services: increased chances of quitting. 2012. London: National Centre for Smoking Cessation and Training
7. NCSCT. National Centre For Smoking Cessation and Training. Very Brief Advice on Smoking (VBA+).
Available at: https://elearning.ncsct.co.uk/vba-launch
8. Putcha N, et al. Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort Thorax 2016;71:411-420.
9. Tobacco Dependence Adviser Training Course: Inpatient Mental Health 1 Module 3: Understanding tobacco dependence in people with SMI. 2024
Available at: https://www.ncsct.co.uk/publications/inpatient-mental-health-training-modules
10. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Cochrane Database of Systematic Reviews 2013, Issue 5.Art.No.:CD009329.DOI: 10.1002/14651858.CD009329.pub2
11. Lindson N et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.
Cochrane Database Syst Rev. 2023 Jun 19;6(6):CD013308.
12. Data on file; QuickMist vaping study, 2022.
13. Hansson A, Hajek P, Perfekt R, et al. Effects of nicotine mouth spray on urges to smoke, a randomised clinical trial. BMJ Open 2012;2:e001618.
doi:10.1136/ bmjopen-2012-001618. Available at: https://bmjopen.bmj.com/content/bmjopen/2/5/e001618.full.pdf
14. Nicorette® 15mg Inhalator Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/4707/smpc
15. Nicorette® QuickMist 1mg/spray mouthspray Summary of Product Characteristics.
Available at: https://www.medicines.org.uk/emc/product/5956/smpc
Online references last accessed September 2024
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/
Adverse events should also be reported to McNeil Products Limited on freephone 0808 238 9999.